Maralixibat
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Review Article: Ileal Bile Acid Transport (IBAT) Inhibitors as an Emerging Treatment for Cholestatic Liver Disease.
Journal: Alimentary pharmacology & therapeutics
Published: December 02, 2025
Exploring Maralixibat for Treatment-Resistant Pruritus in Intrahepatic Cholestasis of Pregnancy and Primary Biliary Cholangitis: A Case Report.
Journal: The American journal of case reports
Published: November 18, 2025
Ileal Bile Acid Transporter Inhibitors in Cholestasis: Potential for More Than Just Paediatrics?
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 17, 2025
Letter to The Editor, Regarding "Indirect Comparison of Maralixibat and Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis" Recently Published by Lacey and Colleagues.
Journal: Clinical therapeutics
Published: October 31, 2025
Beyond pruritus in Alagille syndrome: potential effects of maralixibat on fibrosis and portal hypertension-insights from two case studies.
Journal: Frontiers in medicine
Published: September 17, 2025
Efficacy of ileal bile acid transport inhibitors in children with Alagille syndrome: a meta-analysis.
Journal: European journal of pediatrics
Published: August 18, 2025
Treatment of intractable pruritus with maralixibat in patients with Alagille syndrome before and after reversal of biliary diversion.
Journal: JPGN reports
Published: May 16, 2025
New hope in treating progressive familial intrahepatic cholestasis in children.
Journal: World journal of hepatology
Published: April 09, 2025
Ileal bile acid transporter inhibitors in Alagille syndrome and Progressive Familial Intrahepatic Cholestasis: A systematic review into dose-response.
Journal: British journal of clinical pharmacology
Published: March 24, 2025
Last Updated: 04/28/2026